Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 2 study of delayed-release nicotine (Nicolon) in mild-to-moderate ulcerative colitis
2006-006052-35Phase 2Completed
- Sponsor
- SLA Pharma
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Nicolon in autoimmune colitis, sponsored by SLA Pharma. Primary endpoints: Number of subjects on each dose level at Day 28 and Incidence of adverse events during the study. Started May 2007; status: completed.
02
Drugs
Nicolon
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2006-006052-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006052-35.